Company profile: Ionetix
1.1 - Company Overview
Company description
- Provider of end-to-end radiopharmaceutical solutions for cardiac PET imaging, including N-13 Ammonia for myocardial perfusion; the ION-12SC compact superconducting cyclotron for on/near-campus N-13 production; Cardiac PET consultative services (layout, regulatory, camera/software, training); and targeted alpha therapy using Actinium-225 and Astatine-211 to target cancer cells.
Products and services
- N-13 Ammonia: A clinical-use cardiac radiopharmaceutical used in PET to image the myocardium and evaluate myocardial perfusion in patients with suspected or existing coronary artery disease
- Cardiac PET Consultative Services: End-to-end program support delivering layout consultation, regulatory assistance, camera and software selection, and training to implement Cardiac PET Imaging Programs
- ION-12SC Cyclotron System: A compact accelerator engineered to produce N-13 Ammonia, utilizing superconducting magnets and a smaller footprint for installation on or near medical campuses
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ionetix
Relypsa
HQ: United States
Website
- Description: Provider of biopharmaceutical research and development of non-absorbed polymeric drugs for cardiovascular and renal diseases, specializing in iron deficiency, nephrology, and cardio-renal therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Relypsa company profile →
Tenaya Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage gene and small molecule therapies for heart diseases, including TN-201 for MYBPC3-associated hypertrophic cardiomyopathy, TN-401 for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, and TN-301, an HDAC6 inhibitor for heart failure with preserved ejection fraction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tenaya Therapeutics company profile →
DeVoro Medical
HQ: United States
Website
- Description: Provider of thrombectomy medical devices to restore blood flow, including the WOLF Thrombectomy Platform that captures and removes blood clots from the arterial and venous systems using finger-like prongs, without the need for a console or lytic agents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DeVoro Medical company profile →
LeMaitre
HQ: United States
Website
- Description: Provider of medical devices and implants for the treatment of peripheral vascular diseases, including RestoreFlow, a tissue processing division supplying human tissue allografts for peripheral vascular and cardiac disease, and the LeMaitre Valvulotome, a device that cuts valves in peripheral veins without direct vision for lower extremity arterial disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LeMaitre company profile →
Puzzle Medical
HQ: Canada
Website
- Description: Provider of minimally invasive long-term hemodynamic transcatheter pump solutions for advanced heart failure. Offers ModulHeart, a modular percutaneous heart pump supporting cardiac and renal function via multiple pumps anchored in parallel in the descending aorta, a portable controller with a long-life battery for autonomous operation, and a bedside monitoring station for cath lab programming and monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Puzzle Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ionetix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ionetix
2.2 - Growth funds investing in similar companies to Ionetix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ionetix
4.2 - Public trading comparable groups for Ionetix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →